cagrilintide clinical trial Scorecard: REDEFINE 1 and 2 CagriSema Reduces Blood Pressure in
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 Hypertension dosing for cagrilintide Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Weight loss medicine is entering a new phase. CagriSema is one of the most talked about emerging therapies right nowand for good reason. This dual agonist approach combines: Semaglutide (GLP 1) Cagrilintide (amylin
Pay in 4 interest-free payments of $6.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


